TY - JOUR
T1 - Hydralazine in Pulmonary Hypertension
AU - Rozkovec, A.
AU - Stradling, J.
AU - Minty, K.
AU - Shepherd, G.
AU - Oakley, C. M.
AU - Kastanos, Nikos
AU - Estopá, R.
AU - Rodríguez-Roisin, R.
AU - Agustí-Vidai, A.
AU - Reele, Stots B.
AU - Packer, Milton
AU - Greenberg, Barry
AU - Massie, Barry
AU - Dash, Harold
PY - 1982/11/4
Y1 - 1982/11/4
N2 - To the Editor: The symptomatic fall in blood pressure with one ensuing death after administration of hydralazine to 13 patients with pulmonary hypertension recently described by Packer et al.1 is alarming. Only some patients with severe pulmonary hypertension still have a lung bed capable of dilatation.2 In those who do not, cardiac output is limited by high pulmonary vascular resistance,2,3 and the only effect of an unselective vasodilator is to cause systemic hypotension. The adverse results obtained with hydralazine strongly argue for an initial assessment of the potential reversibility of high pulmonary vascular resistance, using either a selective pulmonary.
AB - To the Editor: The symptomatic fall in blood pressure with one ensuing death after administration of hydralazine to 13 patients with pulmonary hypertension recently described by Packer et al.1 is alarming. Only some patients with severe pulmonary hypertension still have a lung bed capable of dilatation.2 In those who do not, cardiac output is limited by high pulmonary vascular resistance,2,3 and the only effect of an unselective vasodilator is to cause systemic hypotension. The adverse results obtained with hydralazine strongly argue for an initial assessment of the potential reversibility of high pulmonary vascular resistance, using either a selective pulmonary.
UR - http://www.scopus.com/inward/record.url?scp=0020474946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020474946&partnerID=8YFLogxK
U2 - 10.1056/NEJM198211043071917
DO - 10.1056/NEJM198211043071917
M3 - Letter
C2 - 7121553
AN - SCOPUS:0020474946
SN - 0028-4793
VL - 307
SP - 1214
EP - 1216
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 19
ER -